KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cognex (CGNX) Cash & Equivalents (2016 - 2026)

Cognex filings provide 17 years of Cash & Equivalents readings, the most recent being $262.9 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 41.29% to $262.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $262.9 million, a 41.29% increase, with the full-year FY2025 number at $262.9 million, up 41.29% from a year prior.
  • Cash & Equivalents hit $262.9 million in Q4 2025 for Cognex, up from $245.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $395.5 million in Q4 2023 to a low of $524000.0 in Q3 2022.
  • Median Cash & Equivalents over the past 5 years was $186.1 million (2021), compared with a mean of $188.7 million.
  • Biggest five-year swings in Cash & Equivalents: crashed 99.76% in 2022 and later surged 33771.18% in 2023.
  • Cognex's Cash & Equivalents stood at $186.2 million in 2021, then fell by 2.57% to $181.4 million in 2022, then grew by 11.73% to $202.7 million in 2023, then dropped by 8.17% to $186.1 million in 2024, then skyrocketed by 41.29% to $262.9 million in 2025.
  • The last three reported values for Cash & Equivalents were $262.9 million (Q4 2025), $245.9 million (Q3 2025), and $179.3 million (Q2 2025) per Business Quant data.